Crohn's & Colitis 360

Inflammation significantly alters mucosal transcriptomic signatures in pediatric inflammatory Bowel Disease Open Access

• Abstracts
• Lay summary
• Supplementary data

Influenza Vaccine Uptake Among Patients with Inflammatory Bowel Disease: Comparable Outcomes Between Telemedicine and In-Person Care Open Access

• Abstracts
• Lay summary

Child and parent perspectives in IBD management: a literature review and qualitative study Open Access

• Abstract
• Lay summary
• Supplementary data

Early proactive therapeutic drug monitoring with ustekinumab therapy in pediatric Crohn’s disease: data from the prospective Canadian children IBD network Open Access

• Abstracts
• Lay summary
• Supplementary data

Impact of mirikizumab on patient-reported outcomes and quality of life in patients with Crohn’s disease: results from the phase 2 SERENITY study Open Access

• Abstract
• Lay summary
• Supplementary data

Transabdominal intestinal ultrasound versus transmural histopathological findings in severe ulcerative colitis requiring colectomy Open Access

• Abstract
• Lay summary

Balancing safety and effectiveness: parent preferences for fecal microbiota transplant and established therapies in pediatric inflammatory bowel disease—results of a multicenter Canadian study Open Access

• Abstracts
• Lay summary
• Supplementary data

Local prevalence and management of Janus kinase inhibitor-induced acne among adolescents with inflammatory bowel disease Open Access

• Abstract
• Lay summary

Impact of missing patient report outcomes in clinical trials for ulcerative colitis: Should we always assume treatment failure? Open Access

• Abstracts
• Lay summary
• Supplementary data

Erythema nodosum as a marker for objective disease activity in inflammatory bowel disease Open Access

• Abstracts
• Lay summary

Association between serum leucine-rich alpha-2-glycoprotein levels and characteristic enteroclysis findings in small intestinal Crohn’s disease Open Access

• Abstracts
• Lay summary

Patient-led thematic analysis on the impact of living with inflammatory bowel disease: a contemporary appraisal of 415 patient-reported outcomes to improve care and research Open Access

• Abstracts
• Lay summary

Fatigue in pediatric patients with inflammatory bowel disease: a multicenter study by the SEGHNP Open Access

• Abstract
• Lay summary

Subcutaneous infliximab in inflammatory bowel disease: bridging the gap between theory and practice Open Access

• Abstract
• Lay summary
• Supplementary data

Patients’ attitudes to disease prevention in inflammatory bowel disease: a US-based survey Open Access

• Abstracts
• Lay summary
• Supplementary data

Treat-to-Target in Inflammatory Bowel Diseases: Lessons from Screening in a Pragmatic Clinical Trial Open Access

• Abstract
• Lay summary

Safety and efficacy of long-term filgotinib treatment in Japanese patients with ulcerative colitis: an interim subgroup analysis of the SELECTION long-term extension study Open Access

• Abstract
• Lay summary
• Supplementary data

Pharmacokinetics and efficacy of subcutaneous infliximab 120 mg every 2 weeks: a post hoc comparison with intravenous dosing in a phase 1 study in patients with inflammatory bowel disease Open Access

• Abstracts
• Lay summary
• Supplementary data

Genetic proof of herpesviruses CMV, EBV and HHV-6 in intestinal biopsies from patients with inflammatory bowel diseases: prevalence and disease characteristics Open Access

• Abstract